Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07908069
NA

Efficacy, Satisfaction, And Safety Of Cellulite Treatment Using Collagen Biostimulators

Sponsor: Antony Barbosa Institute

View on ClinicalTrials.gov

Summary

This study will evaluate the efficacy, satisfaction, and safety of two collagen biostimulators used to treat cellulite: poly-L-lactic acid (PLLA) and calcium hydroxyapatite (CaHA). Cellulite is a common aesthetic condition characterized by depressions, irregularities, and nodules on the surface of the skin. The study will include 30 adult women with grade 2 or 3 cellulite affecting the buttocks or posterior thighs. The study will use a randomized, double-blind, split-body design. Each participant will receive both treatments, with one side of the body treated with PLLA and the other side treated with CaHA. The side receiving each treatment will be determined randomly. The severity of cellulite will be assessed using a standardized cellulite severity scale. Treatment efficacy, participant satisfaction, and safety will also be evaluated using the Global Aesthetic Improvement Scale, a Net Promoter Score (NPS), clinical assessments, and photographic documentation. The study is intended to provide comparative information about the efficacy, satisfaction, and safety of PLLA and CaHA for the treatment of cellulite. The findings may contribute to clinical decision-making regarding the use of collagen biostimulators for this condition.

Official title: Efficacy, Satisfaction, And Safety Of Cellulite Treatment Using Collagen Biostimulators: A Randomized, Double-Blind Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-06-01

Completion Date

2025-10-30

Last Updated

2026-10-30

Healthy Volunteers

No

Conditions

Interventions

DRUG

Poly-L-Lactic Acid

Poly-L-lactic acid (PLLA)-based collagen biostimulator administered for the treatment of cellulite.

DRUG

Calcium Hydroxyapatite

Calcium hydroxyapatite (CaHA)-based collagen biostimulator administered for the treatment of cellulite.

Locations (1)

Antony Barbosa Institute

Belo Horizonte, Minas Gerais, Brazil